$10.77
0[0.00%]
At close: May 10
Santen Pharmaceutical
(OTCPK:SNPHY)Santen Pharmaceutical Stock (OTC:SNPHY), Earnings Estimates, EPS, and Revenue
Santen Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS
$0.250
Quarterly Revenue
$508.1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$302B
Analyze the earnings history of Santen Pharmaceutical using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Santen Pharmaceutical (OTCPK:SNPHY) reporting earnings?
Santen Pharmaceutical (SNPHY) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on November 7, 2023 for Q2.
What were the latest earnings per share (EPS) for Santen Pharmaceutical (OTCPK:SNPHY)?
The Actual EPS was $0.25, which beat the estimate of $0.00.
What were Santen Pharmaceutical’s (OTCPK:SNPHY) revenues?
The Actual Revenue was $508.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.